LeHavreV1, Hal, Curation, bibRecord, 000153

Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

Identifieur interne : 000153 ( Hal/Curation ); précédent : 000152; suivant : 000154

Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

Auteurs : Leonard Minuk ; Jean-Claude Eisenmann ; Bertrand Arnulf [France] ; Letizia Canepa [Italie] ; Alberto Fragasso [Italie] ; Serge Leyvraz ; Christian Langer ; Yousef Ezaydi ; Dan T. Vogl ; Pilar Giraldo-Castellano ; Sung-Soo Yoon ; Charles Zarnitsky [France] ; Martine Escoffre-Barbe [France] ; Bernard Lemieux ; Kevin Song ; Nizar Jacques Bahlis ; Shien Guo ; Mara Silva Monzini ; Annette Ervin-Haynes ; Vanessa Houck ; Thierry Facon [France] ; Michel Delforge [Belgique]

Source :

RBID : Hal:hal-01274909

English descriptors

mix :
- 80 and over, Aged, Antineoplastic Combined Chemotherapy Protocols, Cross-Sectional Studies, Dexamethasone, Female, Health Status, Humans, Male, Melphalan, Multiple Myeloma, Prednisone, Quality of Life, Thalidomide, Aged.

Abstract

We compared the health-related quality-of-life of patients with newly diagnosed multiple myeloma aged over 65 years or transplant-ineligible in the pivotal, phase III FIRST trial. Patients received: i) continuous lenalidomide and low-dose dexamethasone until disease progression; ii) fixed cycles of lenalidomide and low-dose dexamethasone for 18 months; or iii) fixed cycles of melphalan, prednisone, thalidomide for 18 months. Data were collected using the validated questionnaires (QLQ-MY20, QLQ-C30, and EQ-5D). The analysis focused on the EQ-5D utility value and six domains pre-selected for their perceived clinical relevance. Lenalidomide and low-dose dexamethasone, and melphalan, prednisone, thalidomide improved patients' health-related quality-of-life from baseline over the duration of the study across all pre-selected domains of the QLQ-C30 and EQ-5D. In the QLQ-MY20, lenalidomide and low-dose dexamethasone demonstrated a significantly greater reduction in the Disease Symptoms domain compared with melphalan, prednisone, thalidomide at Month 3, and significantly lower scores for QLQ-MY20 Side Effects of Treatment at all post-baseline assessments except Month 18. Linear mixed-model repeated-measures analyses confirmed the results observed in the cross-sectional analysis. Continuous lenalidomide and low-dose dexamethasone delays disease progression versus melphalan, prednisone, thalidomide and has been associated with a clinically meaningful improvement in health-related quality-of-life. These results further establish continuous lenalidomide and low-dose dexamethasone as a new standard of care for initial therapy of myeloma by demonstrating superior health-related quality-of-life during treatment, compared with melphalan, prednisone, thalidomide

Url:

https://hal-univ-rennes1.archives-ouvertes.fr/hal-01274909

DOI: 10.3324/haematol.2014.120121

Links toward previous steps (curation, corpus...)

to stream Hal, to step Corpus: Pour aller vers cette notice dans l'étape Curation :000153

Links to Exploration step

Hal:hal-01274909

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide</title>
<author><name sortKey="Minuk, Leonard" sort="Minuk, Leonard" uniqKey="Minuk L" first="Leonard" last="Minuk">Leonard Minuk</name>
</author>
<author><name sortKey="Eisenmann, Jean Claude" sort="Eisenmann, Jean Claude" uniqKey="Eisenmann J" first="Jean-Claude" last="Eisenmann">Jean-Claude Eisenmann</name>
</author>
<author><name sortKey="Arnulf, Bertrand" sort="Arnulf, Bertrand" uniqKey="Arnulf B" first="Bertrand" last="Arnulf">Bertrand Arnulf</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-59067" status="VALID">  <orgName>Service d'hématologie biologique</orgName>
  <desc>    <address>      <addrLine>75010 Paris</addrLine>
      <country key="FR"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-300068" type="direct"></relation>
    <relation active="#struct-300135" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-300068" type="direct"><org type="institution" xml:id="struct-300068" status="VALID">  <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
<tutelle active="#struct-300135" type="direct"><org type="institution" xml:id="struct-300135" status="VALID">  <orgName>Hôpital Saint-Louis</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Canepa, Letizia" sort="Canepa, Letizia" uniqKey="Canepa L" first="Letizia" last="Canepa">Letizia Canepa</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-112531" status="INCOMING">  <orgName>Department of Haematology and Oncology</orgName>
  <desc>    <address>      <addrLine>Viale Benedetto XV, N 6;16132;Genova</addrLine>
      <country key="IT"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-327006" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-327006" type="direct"><org type="institution" xml:id="struct-327006" status="INCOMING">  <orgName>University of Genova, San Martino Hospital</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Fragasso, Alberto" sort="Fragasso, Alberto" uniqKey="Fragasso A" first="Alberto" last="Fragasso">Alberto Fragasso</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-118562" status="INCOMING">  <orgName>Internal Medicine</orgName>
  <desc>    <address>      <addrLine>Matera</addrLine>
      <country key="IT"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-328745" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-328745" type="direct"><org type="institution" xml:id="struct-328745" status="INCOMING">  <orgName>Madonna delle Grazie Hospital</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Leyvraz, Serge" sort="Leyvraz, Serge" uniqKey="Leyvraz S" first="Serge" last="Leyvraz">Serge Leyvraz</name>
</author>
<author><name sortKey="Langer, Christian" sort="Langer, Christian" uniqKey="Langer C" first="Christian" last="Langer">Christian Langer</name>
</author>
<author><name sortKey="Ezaydi, Yousef" sort="Ezaydi, Yousef" uniqKey="Ezaydi Y" first="Yousef" last="Ezaydi">Yousef Ezaydi</name>
</author>
<author><name sortKey="Vogl, Dan T" sort="Vogl, Dan T" uniqKey="Vogl D" first="Dan T." last="Vogl">Dan T. Vogl</name>
</author>
<author><name sortKey="Giraldo Castellano, Pilar" sort="Giraldo Castellano, Pilar" uniqKey="Giraldo Castellano P" first="Pilar" last="Giraldo-Castellano">Pilar Giraldo-Castellano</name>
</author>
<author><name sortKey="Yoon, Sung Soo" sort="Yoon, Sung Soo" uniqKey="Yoon S" first="Sung-Soo" last="Yoon">Sung-Soo Yoon</name>
</author>
<author><name sortKey="Zarnitsky, Charles" sort="Zarnitsky, Charles" uniqKey="Zarnitsky C" first="Charles" last="Zarnitsky">Charles Zarnitsky</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-213170" status="INCOMING">  <orgName>Service de Rhumatologie - CH Le Havre</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-352019" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-352019" type="direct"><org type="institution" xml:id="struct-352019" status="INCOMING">  <orgName>CH Le Havre</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Escoffre Barbe, Martine" sort="Escoffre Barbe, Martine" uniqKey="Escoffre Barbe M" first="Martine" last="Escoffre-Barbe">Martine Escoffre-Barbe</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-33415" status="VALID">  <orgName>Service d'hématologie clinique</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
    <ref type="url">http://www.chu-rennes.fr/</ref>
  </desc>
  <listRelation>    <relation active="#struct-105160" type="direct"></relation>
    <relation active="#struct-300129" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-105160" type="direct"><org type="institution" xml:id="struct-105160" status="VALID">  <orgName>Université de Rennes 1</orgName>
  <orgName type="acronym">UR1</orgName>
  <desc>    <address>      <addrLine>2 rue du Thabor - CS 46510 - 35065 Rennes cedex</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.univ-rennes1.fr/</ref>
  </desc>
</org>
</tutelle>
<tutelle active="#struct-300129" type="direct"><org type="institution" xml:id="struct-300129" status="VALID">  <orgName>Hôpital Pontchaillou</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Rennes</settlement>
<region type="region" nuts="2">Région Bretagne</region>
</placeName>
<orgName type="university">Université de Rennes 1</orgName>
<orgName type="institution" wicri:auto="newGroup">Université européenne de Bretagne</orgName>
</affiliation>
</author>
<author><name sortKey="Lemieux, Bernard" sort="Lemieux, Bernard" uniqKey="Lemieux B" first="Bernard" last="Lemieux">Bernard Lemieux</name>
</author>
<author><name sortKey="Song, Kevin" sort="Song, Kevin" uniqKey="Song K" first="Kevin" last="Song">Kevin Song</name>
</author>
<author><name sortKey="Bahlis, Nizar Jacques" sort="Bahlis, Nizar Jacques" uniqKey="Bahlis N" first="Nizar Jacques" last="Bahlis">Nizar Jacques Bahlis</name>
</author>
<author><name sortKey="Guo, Shien" sort="Guo, Shien" uniqKey="Guo S" first="Shien" last="Guo">Shien Guo</name>
</author>
<author><name sortKey="Monzini, Mara Silva" sort="Monzini, Mara Silva" uniqKey="Monzini M" first="Mara Silva" last="Monzini">Mara Silva Monzini</name>
</author>
<author><name sortKey="Ervin Haynes, Annette" sort="Ervin Haynes, Annette" uniqKey="Ervin Haynes A" first="Annette" last="Ervin-Haynes">Annette Ervin-Haynes</name>
</author>
<author><name sortKey="Houck, Vanessa" sort="Houck, Vanessa" uniqKey="Houck V" first="Vanessa" last="Houck">Vanessa Houck</name>
</author>
<author><name sortKey="Facon, Thierry" sort="Facon, Thierry" uniqKey="Facon T" first="Thierry" last="Facon">Thierry Facon</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-7524" status="VALID">  <orgName>Hôpital Claude Huriez</orgName>
  <desc>    <address>      <addrLine>59037 Lille</addrLine>
      <country key="FR"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-361611" type="direct"></relation>
    <relation active="#struct-425779" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-361611" type="direct"><org type="institution" xml:id="struct-361611" status="VALID">  <idno type="IdRef">026404389</idno>
  <orgName>Université de Lille, Droit et Santé</orgName>
  <desc>    <address>      <addrLine>42 rue Paul Duez 59000 Lille</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.univ-lille2.fr/</ref>
  </desc>
</org>
</tutelle>
<tutelle active="#struct-425779" type="direct"><org type="institution" xml:id="struct-425779" status="VALID">  <orgName>Centre Hospitalier Régional Universitaire [Lille]</orgName>
  <orgName type="acronym">CHRU Lille</orgName>
  <desc>    <address>      <addrLine>2, avenue Oscar Lambret - 59037 Lille Cedex</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.chru-lille.fr/</ref>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Delforge, Michel" sort="Delforge, Michel" uniqKey="Delforge M" first="Michel" last="Delforge">Michel Delforge</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-164483" status="INCOMING">  <orgName>Universitaire Ziekenhuizen Leuven</orgName>
  <desc>    <address>      <addrLine>Campus Gasthuisberg, Herestraat 49;3000;Leuven</addrLine>
      <country key="BE"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-341700" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-341700" type="direct"><org type="institution" xml:id="struct-341700" status="INCOMING">  <orgName>Universitaire Ziekenhuizen Leuven</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Belgique</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">HAL</idno>
<idno type="RBID">Hal:hal-01274909</idno>
<idno type="halId">hal-01274909</idno>
<idno type="halUri">https://hal-univ-rennes1.archives-ouvertes.fr/hal-01274909</idno>
<idno type="url">https://hal-univ-rennes1.archives-ouvertes.fr/hal-01274909</idno>
<idno type="doi">10.3324/haematol.2014.120121</idno>
<date when="2015-06">2015-06</date>
<idno type="wicri:Area/Hal/Corpus">000153</idno>
<idno type="wicri:Area/Hal/Curation">000153</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide</title>
<author><name sortKey="Minuk, Leonard" sort="Minuk, Leonard" uniqKey="Minuk L" first="Leonard" last="Minuk">Leonard Minuk</name>
</author>
<author><name sortKey="Eisenmann, Jean Claude" sort="Eisenmann, Jean Claude" uniqKey="Eisenmann J" first="Jean-Claude" last="Eisenmann">Jean-Claude Eisenmann</name>
</author>
<author><name sortKey="Arnulf, Bertrand" sort="Arnulf, Bertrand" uniqKey="Arnulf B" first="Bertrand" last="Arnulf">Bertrand Arnulf</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-59067" status="VALID">  <orgName>Service d'hématologie biologique</orgName>
  <desc>    <address>      <addrLine>75010 Paris</addrLine>
      <country key="FR"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-300068" type="direct"></relation>
    <relation active="#struct-300135" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-300068" type="direct"><org type="institution" xml:id="struct-300068" status="VALID">  <orgName>Assistance publique - Hôpitaux de Paris (AP-HP)</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
<tutelle active="#struct-300135" type="direct"><org type="institution" xml:id="struct-300135" status="VALID">  <orgName>Hôpital Saint-Louis</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Canepa, Letizia" sort="Canepa, Letizia" uniqKey="Canepa L" first="Letizia" last="Canepa">Letizia Canepa</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-112531" status="INCOMING">  <orgName>Department of Haematology and Oncology</orgName>
  <desc>    <address>      <addrLine>Viale Benedetto XV, N 6;16132;Genova</addrLine>
      <country key="IT"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-327006" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-327006" type="direct"><org type="institution" xml:id="struct-327006" status="INCOMING">  <orgName>University of Genova, San Martino Hospital</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Fragasso, Alberto" sort="Fragasso, Alberto" uniqKey="Fragasso A" first="Alberto" last="Fragasso">Alberto Fragasso</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-118562" status="INCOMING">  <orgName>Internal Medicine</orgName>
  <desc>    <address>      <addrLine>Matera</addrLine>
      <country key="IT"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-328745" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-328745" type="direct"><org type="institution" xml:id="struct-328745" status="INCOMING">  <orgName>Madonna delle Grazie Hospital</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Italie</country>
</affiliation>
</author>
<author><name sortKey="Leyvraz, Serge" sort="Leyvraz, Serge" uniqKey="Leyvraz S" first="Serge" last="Leyvraz">Serge Leyvraz</name>
</author>
<author><name sortKey="Langer, Christian" sort="Langer, Christian" uniqKey="Langer C" first="Christian" last="Langer">Christian Langer</name>
</author>
<author><name sortKey="Ezaydi, Yousef" sort="Ezaydi, Yousef" uniqKey="Ezaydi Y" first="Yousef" last="Ezaydi">Yousef Ezaydi</name>
</author>
<author><name sortKey="Vogl, Dan T" sort="Vogl, Dan T" uniqKey="Vogl D" first="Dan T." last="Vogl">Dan T. Vogl</name>
</author>
<author><name sortKey="Giraldo Castellano, Pilar" sort="Giraldo Castellano, Pilar" uniqKey="Giraldo Castellano P" first="Pilar" last="Giraldo-Castellano">Pilar Giraldo-Castellano</name>
</author>
<author><name sortKey="Yoon, Sung Soo" sort="Yoon, Sung Soo" uniqKey="Yoon S" first="Sung-Soo" last="Yoon">Sung-Soo Yoon</name>
</author>
<author><name sortKey="Zarnitsky, Charles" sort="Zarnitsky, Charles" uniqKey="Zarnitsky C" first="Charles" last="Zarnitsky">Charles Zarnitsky</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-213170" status="INCOMING">  <orgName>Service de Rhumatologie - CH Le Havre</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-352019" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-352019" type="direct"><org type="institution" xml:id="struct-352019" status="INCOMING">  <orgName>CH Le Havre</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Escoffre Barbe, Martine" sort="Escoffre Barbe, Martine" uniqKey="Escoffre Barbe M" first="Martine" last="Escoffre-Barbe">Martine Escoffre-Barbe</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-33415" status="VALID">  <orgName>Service d'hématologie clinique</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
    <ref type="url">http://www.chu-rennes.fr/</ref>
  </desc>
  <listRelation>    <relation active="#struct-105160" type="direct"></relation>
    <relation active="#struct-300129" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-105160" type="direct"><org type="institution" xml:id="struct-105160" status="VALID">  <orgName>Université de Rennes 1</orgName>
  <orgName type="acronym">UR1</orgName>
  <desc>    <address>      <addrLine>2 rue du Thabor - CS 46510 - 35065 Rennes cedex</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.univ-rennes1.fr/</ref>
  </desc>
</org>
</tutelle>
<tutelle active="#struct-300129" type="direct"><org type="institution" xml:id="struct-300129" status="VALID">  <orgName>Hôpital Pontchaillou</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
<placeName><settlement type="city">Rennes</settlement>
<region type="region" nuts="2">Région Bretagne</region>
</placeName>
<orgName type="university">Université de Rennes 1</orgName>
<orgName type="institution" wicri:auto="newGroup">Université européenne de Bretagne</orgName>
</affiliation>
</author>
<author><name sortKey="Lemieux, Bernard" sort="Lemieux, Bernard" uniqKey="Lemieux B" first="Bernard" last="Lemieux">Bernard Lemieux</name>
</author>
<author><name sortKey="Song, Kevin" sort="Song, Kevin" uniqKey="Song K" first="Kevin" last="Song">Kevin Song</name>
</author>
<author><name sortKey="Bahlis, Nizar Jacques" sort="Bahlis, Nizar Jacques" uniqKey="Bahlis N" first="Nizar Jacques" last="Bahlis">Nizar Jacques Bahlis</name>
</author>
<author><name sortKey="Guo, Shien" sort="Guo, Shien" uniqKey="Guo S" first="Shien" last="Guo">Shien Guo</name>
</author>
<author><name sortKey="Monzini, Mara Silva" sort="Monzini, Mara Silva" uniqKey="Monzini M" first="Mara Silva" last="Monzini">Mara Silva Monzini</name>
</author>
<author><name sortKey="Ervin Haynes, Annette" sort="Ervin Haynes, Annette" uniqKey="Ervin Haynes A" first="Annette" last="Ervin-Haynes">Annette Ervin-Haynes</name>
</author>
<author><name sortKey="Houck, Vanessa" sort="Houck, Vanessa" uniqKey="Houck V" first="Vanessa" last="Houck">Vanessa Houck</name>
</author>
<author><name sortKey="Facon, Thierry" sort="Facon, Thierry" uniqKey="Facon T" first="Thierry" last="Facon">Thierry Facon</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-7524" status="VALID">  <orgName>Hôpital Claude Huriez</orgName>
  <desc>    <address>      <addrLine>59037 Lille</addrLine>
      <country key="FR"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-361611" type="direct"></relation>
    <relation active="#struct-425779" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-361611" type="direct"><org type="institution" xml:id="struct-361611" status="VALID">  <idno type="IdRef">026404389</idno>
  <orgName>Université de Lille, Droit et Santé</orgName>
  <desc>    <address>      <addrLine>42 rue Paul Duez 59000 Lille</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.univ-lille2.fr/</ref>
  </desc>
</org>
</tutelle>
<tutelle active="#struct-425779" type="direct"><org type="institution" xml:id="struct-425779" status="VALID">  <orgName>Centre Hospitalier Régional Universitaire [Lille]</orgName>
  <orgName type="acronym">CHRU Lille</orgName>
  <desc>    <address>      <addrLine>2, avenue Oscar Lambret - 59037 Lille Cedex</addrLine>
      <country key="FR"></country>
    </address>
    <ref type="url">http://www.chru-lille.fr/</ref>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Delforge, Michel" sort="Delforge, Michel" uniqKey="Delforge M" first="Michel" last="Delforge">Michel Delforge</name>
<affiliation wicri:level="1"><hal:affiliation type="laboratory" xml:id="struct-164483" status="INCOMING">  <orgName>Universitaire Ziekenhuizen Leuven</orgName>
  <desc>    <address>      <addrLine>Campus Gasthuisberg, Herestraat 49;3000;Leuven</addrLine>
      <country key="BE"></country>
    </address>
  </desc>
  <listRelation>    <relation active="#struct-341700" type="direct"></relation>
  </listRelation>
<tutelles><tutelle active="#struct-341700" type="direct"><org type="institution" xml:id="struct-341700" status="INCOMING">  <orgName>Universitaire Ziekenhuizen Leuven</orgName>
  <desc>    <address>      <country key="FR"></country>
    </address>
  </desc>
</org>
</tutelle>
</tutelles>
</hal:affiliation>
<country>Belgique</country>
</affiliation>
</author>
</analytic>
<idno type="DOI">10.3324/haematol.2014.120121</idno>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="mix" xml:lang="en"><term> 80 and over</term>
<term> Aged</term>
<term> Antineoplastic Combined Chemotherapy Protocols</term>
<term> Cross-Sectional Studies</term>
<term> Dexamethasone</term>
<term> Female</term>
<term> Health Status</term>
<term> Humans</term>
<term> Male</term>
<term> Melphalan</term>
<term> Multiple Myeloma</term>
<term> Prednisone</term>
<term> Quality of Life</term>
<term> Thalidomide</term>
<term>Aged</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">We compared the health-related quality-of-life of patients with newly diagnosed multiple myeloma aged over 65 years or transplant-ineligible in the pivotal, phase III FIRST trial. Patients received: i) continuous lenalidomide and low-dose dexamethasone until disease progression; ii) fixed cycles of lenalidomide and low-dose dexamethasone for 18 months; or iii) fixed cycles of melphalan, prednisone, thalidomide for 18 months. Data were collected using the validated questionnaires (QLQ-MY20, QLQ-C30, and EQ-5D). The analysis focused on the EQ-5D utility value and six domains pre-selected for their perceived clinical relevance. Lenalidomide and low-dose dexamethasone, and melphalan, prednisone, thalidomide improved patients' health-related quality-of-life from baseline over the duration of the study across all pre-selected domains of the QLQ-C30 and EQ-5D. In the QLQ-MY20, lenalidomide and low-dose dexamethasone demonstrated a significantly greater reduction in the Disease Symptoms domain compared with melphalan, prednisone, thalidomide at Month 3, and significantly lower scores for QLQ-MY20 Side Effects of Treatment at all post-baseline assessments except Month 18. Linear mixed-model repeated-measures analyses confirmed the results observed in the cross-sectional analysis. Continuous lenalidomide and low-dose dexamethasone delays disease progression versus melphalan, prednisone, thalidomide and has been associated with a clinically meaningful improvement in health-related quality-of-life. These results further establish continuous lenalidomide and low-dose dexamethasone as a new standard of care for initial therapy of myeloma by demonstrating superior health-related quality-of-life during treatment, compared with melphalan, prednisone, thalidomide</div>
</front>
</TEI>
<hal api="V3">          <titleStmt>            <title xml:lang="en">Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide</title>
            <author role="aut">              <persName>                <forename type="first">Leonard</forename>
                <surname>Minuk</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294915</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Jean-Claude</forename>
                <surname>Eisenmann</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294916</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Bertrand</forename>
                <surname>Arnulf</surname>
              </persName>
              <email></email>
              <idno type="halauthor">616493</idno>
              <affiliation ref="#struct-59067"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Letizia</forename>
                <surname>Canepa</surname>
              </persName>
              <email></email>
              <idno type="halauthor">544716</idno>
              <affiliation ref="#struct-112531"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Alberto</forename>
                <surname>Fragasso</surname>
              </persName>
              <email></email>
              <idno type="halauthor">502757</idno>
              <affiliation ref="#struct-118562"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Serge</forename>
                <surname>Leyvraz</surname>
              </persName>
              <email></email>
              <idno type="halauthor">847875</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Christian</forename>
                <surname>Langer</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294917</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Yousef</forename>
                <surname>Ezaydi</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294918</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Dan T.</forename>
                <surname>Vogl</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294919</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Pilar</forename>
                <surname>Giraldo-Castellano</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294920</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Sung-Soo</forename>
                <surname>Yoon</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294921</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Charles</forename>
                <surname>Zarnitsky</surname>
              </persName>
              <email></email>
              <idno type="halauthor">637450</idno>
              <affiliation ref="#struct-213170"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Martine</forename>
                <surname>Escoffre-Barbe</surname>
              </persName>
              <email></email>
              <idno type="halauthor">725609</idno>
              <affiliation ref="#struct-33415"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Bernard</forename>
                <surname>Lemieux</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294922</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Kevin</forename>
                <surname>Song</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294923</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Nizar Jacques</forename>
                <surname>Bahlis</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294924</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Shien</forename>
                <surname>Guo</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294925</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Mara Silva</forename>
                <surname>Monzini</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294926</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Annette</forename>
                <surname>Ervin-Haynes</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294927</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Vanessa</forename>
                <surname>Houck</surname>
              </persName>
              <email></email>
              <idno type="halauthor">1294928</idno>
            </author>
            <author role="aut">              <persName>                <forename type="first">Thierry</forename>
                <surname>Facon</surname>
              </persName>
              <email></email>
              <idno type="halauthor">514990</idno>
              <affiliation ref="#struct-7524"></affiliation>
            </author>
            <author role="aut">              <persName>                <forename type="first">Michel</forename>
                <surname>Delforge</surname>
              </persName>
              <email>michel.delforge@uz.kuleuven.ac.be</email>
              <idno type="halauthor">632511</idno>
              <affiliation ref="#struct-164483"></affiliation>
            </author>
            <editor role="depositor">              <persName>                <forename>Laurent</forename>
                <surname>Jonchère</surname>
              </persName>
              <email>laurent.jonchere@univ-rennes1.fr</email>
            </editor>
          </titleStmt>
          <editionStmt>            <edition n="v1" type="current">              <date type="whenSubmitted">2016-02-16 13:57:59</date>
              <date type="whenModified">2016-10-20 14:47:04</date>
              <date type="whenReleased">2016-02-16 13:57:59</date>
              <date type="whenProduced">2015-06</date>
            </edition>
            <respStmt>              <resp>contributor</resp>
              <name key="113861">                <persName>                  <forename>Laurent</forename>
                  <surname>Jonchère</surname>
                </persName>
                <email>laurent.jonchere@univ-rennes1.fr</email>
              </name>
            </respStmt>
          </editionStmt>
          <publicationStmt>            <distributor>CCSD</distributor>
            <idno type="halId">hal-01274909</idno>
            <idno type="halUri">https://hal-univ-rennes1.archives-ouvertes.fr/hal-01274909</idno>
            <idno type="halBibtex">minuk:hal-01274909</idno>
            <idno type="halRefHtml">Haematologica, 2015, 100 (6), pp.826--833. <10.3324/haematol.2014.120121></idno>
            <idno type="halRef">Haematologica, 2015, 100 (6), pp.826--833. <10.3324/haematol.2014.120121></idno>
          </publicationStmt>
          <seriesStmt>            <idno type="stamp" n="UNIV-RENNES1">Université de Rennes 1</idno>
            <idno type="stamp" n="HL">Publications CHU - Rennes 1</idno>
            <idno type="stamp" n="STATS-UR1">Statistiques-HAL-UR1</idno>
            <idno type="stamp" n="APHP" p="INSERM">AP-HP</idno>
            <idno type="stamp" n="UR1-HAL">Publications labos UR1 dans HAL-Rennes 1</idno>
            <idno type="stamp" n="UR1-SDV">UR1 - publications SDV</idno>
          </seriesStmt>
          <notesStmt>            <note type="audience" n="2">International</note>
            <note type="popular" n="0">No</note>
            <note type="peer" n="1">Yes</note>
          </notesStmt>
          <sourceDesc>            <biblStruct>              <analytic>                <title xml:lang="en">Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide</title>
                <author role="aut">                  <persName>                    <forename type="first">Leonard</forename>
                    <surname>Minuk</surname>
                  </persName>
                  <idno type="halAuthorId">1294915</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Jean-Claude</forename>
                    <surname>Eisenmann</surname>
                  </persName>
                  <idno type="halAuthorId">1294916</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Bertrand</forename>
                    <surname>Arnulf</surname>
                  </persName>
                  <idno type="halAuthorId">616493</idno>
                  <affiliation ref="#struct-59067"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Letizia</forename>
                    <surname>Canepa</surname>
                  </persName>
                  <idno type="halAuthorId">544716</idno>
                  <affiliation ref="#struct-112531"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Alberto</forename>
                    <surname>Fragasso</surname>
                  </persName>
                  <idno type="halAuthorId">502757</idno>
                  <affiliation ref="#struct-118562"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Serge</forename>
                    <surname>Leyvraz</surname>
                  </persName>
                  <idno type="halAuthorId">847875</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Christian</forename>
                    <surname>Langer</surname>
                  </persName>
                  <idno type="halAuthorId">1294917</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Yousef</forename>
                    <surname>Ezaydi</surname>
                  </persName>
                  <idno type="halAuthorId">1294918</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Dan T.</forename>
                    <surname>Vogl</surname>
                  </persName>
                  <idno type="halAuthorId">1294919</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Pilar</forename>
                    <surname>Giraldo-Castellano</surname>
                  </persName>
                  <idno type="halAuthorId">1294920</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Sung-Soo</forename>
                    <surname>Yoon</surname>
                  </persName>
                  <idno type="halAuthorId">1294921</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Charles</forename>
                    <surname>Zarnitsky</surname>
                  </persName>
                  <idno type="halAuthorId">637450</idno>
                  <affiliation ref="#struct-213170"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Martine</forename>
                    <surname>Escoffre-Barbe</surname>
                  </persName>
                  <idno type="halAuthorId">725609</idno>
                  <affiliation ref="#struct-33415"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Bernard</forename>
                    <surname>Lemieux</surname>
                  </persName>
                  <idno type="halAuthorId">1294922</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Kevin</forename>
                    <surname>Song</surname>
                  </persName>
                  <idno type="halAuthorId">1294923</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Nizar Jacques</forename>
                    <surname>Bahlis</surname>
                  </persName>
                  <idno type="halAuthorId">1294924</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Shien</forename>
                    <surname>Guo</surname>
                  </persName>
                  <idno type="halAuthorId">1294925</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Mara Silva</forename>
                    <surname>Monzini</surname>
                  </persName>
                  <idno type="halAuthorId">1294926</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Annette</forename>
                    <surname>Ervin-Haynes</surname>
                  </persName>
                  <idno type="halAuthorId">1294927</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Vanessa</forename>
                    <surname>Houck</surname>
                  </persName>
                  <idno type="halAuthorId">1294928</idno>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Thierry</forename>
                    <surname>Facon</surname>
                  </persName>
                  <idno type="halAuthorId">514990</idno>
                  <affiliation ref="#struct-7524"></affiliation>
                </author>
                <author role="aut">                  <persName>                    <forename type="first">Michel</forename>
                    <surname>Delforge</surname>
                  </persName>
                  <email>michel.delforge@uz.kuleuven.ac.be</email>
                  <idno type="halAuthorId">632511</idno>
                  <affiliation ref="#struct-164483"></affiliation>
                </author>
              </analytic>
              <monogr>                <idno type="halJournalId" status="INCOMING">106927</idno>
                <title level="j">Haematologica</title>
                <imprint>                  <biblScope unit="volume">100</biblScope>
                  <biblScope unit="issue">6</biblScope>
                  <biblScope unit="pp">826--833</biblScope>
                  <date type="datePub">2015-06</date>
                </imprint>
              </monogr>
              <idno type="doi">10.3324/haematol.2014.120121</idno>
              <idno type="pubmed">25769541</idno>
              <idno type="pubmedcentral">PMC4450629</idno>
            </biblStruct>
          </sourceDesc>
          <profileDesc>            <langUsage>              <language ident="en">English</language>
            </langUsage>
            <textClass>              <keywords scheme="author">                <term xml:lang="en">Aged</term>
                <term xml:lang="en"> Aged</term>
                <term xml:lang="en"> 80 and over</term>
                <term xml:lang="en"> Antineoplastic Combined Chemotherapy Protocols</term>
                <term xml:lang="en"> Cross-Sectional Studies</term>
                <term xml:lang="en"> Dexamethasone</term>
                <term xml:lang="en"> Female</term>
                <term xml:lang="en"> Health Status</term>
                <term xml:lang="en"> Humans</term>
                <term xml:lang="en"> Male</term>
                <term xml:lang="en"> Melphalan</term>
                <term xml:lang="en"> Multiple Myeloma</term>
                <term xml:lang="en"> Prednisone</term>
                <term xml:lang="en"> Quality of Life</term>
                <term xml:lang="en"> Thalidomide</term>
              </keywords>
              <classCode scheme="halDomain" n="sdv">Life Sciences [q-bio]</classCode>
              <classCode scheme="halTypology" n="ART">Journal articles</classCode>
            </textClass>
            <abstract xml:lang="en">We compared the health-related quality-of-life of patients with newly diagnosed multiple myeloma aged over 65 years or transplant-ineligible in the pivotal, phase III FIRST trial. Patients received: i) continuous lenalidomide and low-dose dexamethasone until disease progression; ii) fixed cycles of lenalidomide and low-dose dexamethasone for 18 months; or iii) fixed cycles of melphalan, prednisone, thalidomide for 18 months. Data were collected using the validated questionnaires (QLQ-MY20, QLQ-C30, and EQ-5D). The analysis focused on the EQ-5D utility value and six domains pre-selected for their perceived clinical relevance. Lenalidomide and low-dose dexamethasone, and melphalan, prednisone, thalidomide improved patients' health-related quality-of-life from baseline over the duration of the study across all pre-selected domains of the QLQ-C30 and EQ-5D. In the QLQ-MY20, lenalidomide and low-dose dexamethasone demonstrated a significantly greater reduction in the Disease Symptoms domain compared with melphalan, prednisone, thalidomide at Month 3, and significantly lower scores for QLQ-MY20 Side Effects of Treatment at all post-baseline assessments except Month 18. Linear mixed-model repeated-measures analyses confirmed the results observed in the cross-sectional analysis. Continuous lenalidomide and low-dose dexamethasone delays disease progression versus melphalan, prednisone, thalidomide and has been associated with a clinically meaningful improvement in health-related quality-of-life. These results further establish continuous lenalidomide and low-dose dexamethasone as a new standard of care for initial therapy of myeloma by demonstrating superior health-related quality-of-life during treatment, compared with melphalan, prednisone, thalidomide</abstract>
          </profileDesc>
        </hal>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/France/explor/LeHavreV1/Data/Hal/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000153 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Hal/Curation/biblio.hfd -nk 000153 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/France
   |area=    LeHavreV1
   |flux=    Hal
   |étape=   Curation
   |type=    RBID
   |clé=     Hal:hal-01274909
   |texte=   Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide
}}

This area was generated with Dilib version V0.6.25.
Data generation: Sat Dec 3 14:37:02 2016. Site generation: Tue Mar 5 08:25:07 2024

	Serveur d'exploration sur la visibilité du Havre
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la visibilité du Havre

Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

Health-related quality-of-life in patients with newly diagnosed multiple myeloma in the FIRST trial: lenalidomide plus low-dose dexamethasone versus melphalan, prednisone, thalidomide

Source :

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri